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Adult-onset type II citrullinemia (CTLN2) is a disorder caused by an inborn error of metabolism affecting the liver. CTLN2 is 
an autosomal recessive disorder characterized by recurrent encephalopathy with hyperammonemia due to highly elevated 
plasma levels of citrulline and ammonia, caused by a deficiency of argininosuccinate synthetase in the liver. A small number 
of patients have undergone liver transplantation with favorable results. In Korea, the limitations of the deceased donor pool 
have made living donor liver transplantation a common alternative treatment option. We report the case of a patient with 
type II citrullinemia who was treated successfully with auxiliary partial orthotopic liver transplantation (APOLT) from a liv-
ing donor. This is the first description of an APOLT for a patient with adult onset type II citrullinemia in Korea.
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INTRODUCTION
Urea cycle disorders (UCD) are among the most com-
mon inborn errors of metabolism of the liver. Citrulline-
mia can be classified into three types: neonatal/infantile 
(types I and III) and the adult form (type II) [1]. More than 
20 patients with citrullinemia have undergone liver trans-
plantation, with favorable therapeutic results [2]. Howev-
er, the number of cases with auxiliary partial orthotopic 
liver transplantation (APOLT) is limited. APOLT was ini-
tially performed in patients with acute liver failure and 
non-cirrhotic metabolic liver disease to compensate for en-
zyme deficiencies without complete removal of the native 
liver and for small-for-size living donor grafts [3-5]. We re-
port a successful APOLT for the treatment of adult onset 
type II citrullinemia.
CASE REPORT
Our patient was a 27-year-old man who was diagnosed 
with adult-onset type II citrullinemia (CTLN2) at age 24. 
The patient’s height was 178 cm with a body weight of 60 
kg. The patient had been treated with a low protein diet 
and oral administration of lactulose. Intermittent lactulose 
enemas were provided for intermittent alteration of Bum Soo Kim, et al.
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Fig. 1. On postoperative day 7, abdominal computed tomography 
shows orthotopically transplanted small left lobe graft with 
well-enhanced pattern.
Fig. 2. (A) Direct portography shows the stenosis of left portal vein 
(white arrow heads). (B) The embolization of 8th segmental branch 
of right portal vein was successfully performed. (C) Self-expan-
dable stent placement for left portal vein. After stent placement, 
the left portal flow was improved.
consciousness. Recently, the patient has had more fre-
quent alterations of his mental status with irritability and 
altered consciousness. Even though oral administration of 
L-arginine, Kanamycin and intravenous hyperalimen-
tation with branched chain amino acids was started, his 
plasma levels of ammonia and citrulline were highly ele-
vated, up to 844 μg/dL (normal range, 19 to 87 μg/dL) and 
682 μmol/L (normal range, 12 to 55 μmol/L), respectively. 
Despite the conservative medical treatment including al-
ternative pathway medication, intermittent continuous 
renal replacement therapy and hemodialysis, his con-
dition failed to improve. Therefore, living donor liver 
transplantation was planned using a right lobe graft from 
his 25-year-old sister. However, the estimated volume of 
the donor’s right lobe was 800 mL compared to 180 mL of 
the left and in addition there was a type III portal vein 
anomaly. We eventually decided to perform an APOLT us-
ing the extended left lobe of the liver from the donor. The 
patient underwent APOLT in February of 2008. The actual 
graft volume was 200 g and the graft-to-recipient weight 
ratio (GRWR) was only 0.33%. The patient’s extended left Auxiliary partial orthotopic liver transplantation and adult onset type II citrullinemia
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Fig. 3. On post stent insertion day 7, computed tomography volume
of the graft is increased to 250 mL.
lobe (including caudate lobe) was resected and the ex-
tended left lobe graft (including middle and left hepatic 
vein) was transplanted orthotopically. The left and middle 
hepatic vein trunk of the extended left lobe graft was anas-
tomosed to the left and middle hepatic vein trunk of the re-
cipient in end-to-end fashion with interposition veno-
plasty using the recipient’s greater saphenous vein as a 
patch. The left portal vein of the graft was anastomosed to 
that of the recipient in end-to-end fashion. Considering 
that the graft was too small, the recipient’s right portal vein 
was narrowed by surgical clipping, instead of total di-
version, for prevention of the development of portal ve-
nous hypertension. The left hepatic artery of the graft was 
anastomosed to that of the recipients in end-to-end 
fashion. Intraoperative Doppler ultrasonography demon-
strated that portal and arterial blood flow were well main-
tained in both the native liver and the graft. Biliary drain-
age was accomplished by a Roux-en-Y hepaticojeju-
nostomy. On postoperative day 7, abdominal computed 
tomography demonstrated orthotopically transplanted 
small left lobe graft with well-enhanced pattern (Fig. 1). 
The post-operative course was uneventful and the patient 
was discharged without any problems. The plasma con-
centrations of ammonia were at the upper limits of nor-
mal, so only a low protein diet (50 g/day) was supplied 
without any specific medication. On post-operative day 
33, the patient reported a sudden severe visual dis-
turbance and the plasma levels of ammonia were noted to 
have increased up to 209 μg/dL. The estimated computed 
tomography volume of the graft was decreased to 190 mL 
and a left portal vein stenosis was suspected. Direct por-
tography was performed and a severe left portal vein 
stenosis was confirmed. Immediate coil embolization of 
8th segmental branch of right anterior portal vein and 
self-expandable stent placement for left portal vein was 
performed in order to increase the portal flow to the graft 
(Fig. 2). On post stent insertion day 7, the calculated com-
puted tomography volume of the graft was increased to 
250 mL (Fig. 3). The plasma level of ammonia was within 
normal range. By the thirtieth postoperative month, the 
patient had no signs of rejection or vascular problems.
DISCUSSION
APOLT was initially introduced as a temporary or per-
manent support for patients with fulminant hepatic fail-
ure [6]. Currently, the indications for its use have ex-
panded to include metabolic liver disease. APOLT can 
provide an adequate hepatic mass to correct underlying 
enzyme deficiencies in adult patients with UCD. This pro-
cedure can be carried out to overcome the limitations of 
graft volume in living donor liver transplantation [7]. In 
Korea, deceased donor livers are in limited supply. 
Therefore, living donor liver transplantation is the only 
treatment option for patients with metabolic liver disease 
such as UCD. In this case, the graft weight of 200 g and the 
GRWR of 0.33% are the smallest graft and lowest margin 
ever reported to meet the minimum requirements for the 
demands of adequate metabolic function in adults. The 
post-operative management of this patient is complicated. 
Because the remaining native liver function, except for the 
metabolism of ammonia, is normal, the differential diag-
nosis including portal steal phenomenon and rejection as 
well as other problems associated with the vascular sys-
tem is difficult. Thus the plasma ammonia level is a val-
uable follow up marker and should be closely monitored 
in such patients. In addition, careful monitoring of the por-
tal flow to the graft is important for the detection of de-
layed graft dysfunction. Selective portal vein emboliza-
tion is a useful method for the increase of portal flow to the 
graft. In conclusion, APOLT can be a life saving procedure Bum Soo Kim, et al.
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and an effective treatment for patients with adult-onset 
type II citrullinemia, especially when a deceased donor 
graft is not available or when candidate donors have in-
sufficient graft volume. However, further confirmation is 
needed with additional patients and long-term follow-up. 
How much volume of graft can be transplanted success-
fully is questionable in cases of inborn error of metabo-
lism, such as UCD.
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